Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2006-09-30

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures.

To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples.

The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells

NCT02919709

Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment

UNKNOWN NA

Safety and Validity of Extracorporeal Fenestration and in Situ Fenestration in Patients With Aortic Disease Involving the Left Subclavian Artery

NCT06256757

Aortic Dissection Aneurysm

NOT_YET_RECRUITING NA

Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test

NCT02859662

Abdominal Compartment Syndrome

UNKNOWN

Non Invasive Imaging of Abdominal Aorta Aneurysm Hemodynamics and Wall Structure

NCT01104688

Aortic Aneurysm, Abdominal

COMPLETED

Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm

NCT03093857

Thoracoabdominal Aortic Aneurysm

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysm of the Abdominal Aorta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> or = 18 years
* All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery

Exclusion Criteria

* Patients who do not have aneurysm of the abdominal aorta
* Refusal to sign the consent form for participation
* Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No